Multimodal deep-learning framework that estimates and forecasts abnormal laboratory values directly from a 12-lead ECG plus routinely available demographics, biometrics, and vital signs -- reframing dozens of blood tests as binary classification targets predictable from a test that is already fast, non-invasive, and nearly universal in acute care. A structured state-space (S4) encoder processes the raw ECG waveform and is late-fused with an MLP encoder over the tabular metadata; the same architecture is trained both to estimate the closest lab value within 60 minutes of the ECG ('abnormality prediction') and to forecast whether a value will become abnormal 30/60/120 minutes into the future ('abnormality forecasting'). Trained and evaluated on 385,480 linked ECG-lab-value samples from 127,994 MIMIC-IV patients, the model reaches AUROC > 0.7 for 24 distinct lab abnormalities in the prediction setting and 24 in the forecasting setting, spanning cardiac, renal, hematological, metabolic, immunological, and coagulation categories -- with NT-proBNP elevation the best-predicted marker (AUROC 0.90), followed by hemoglobin, albumin, and hematocrit derangements (AUROC > 0.82). Code for dataset construction, training, and evaluation is public under an MIT license; no pretrained model weights are released.

ECG foundation model built on the xLSTM (extended LSTM) architecture: a bidirectional stack of nine alternating scalar- and matrix-memory LSTM blocks that scales linearly with sequence length, unlike the quadratic cost of transformer-based ECG models. Pretrained with SimDINOv2, a coding-rate-regularized self-distillation (DINO) objective adapted from computer vision to ECG time series, on roughly 8 million recordings from CODE, INCART, and Chapman-Shaoxing-Ningbo. Introduced alongside BenchECG, a standardized 8-dataset/10-task benchmark, on which xECG achieves the best average rank of any publicly available ECG foundation model, with particular strength on long-context tasks (30-minute ambulatory arrhythmia classification, multi-hour sleep-apnea segmentation) where transformer-based models are computationally limited.

Screens 12-lead ECGs for Chagas cardiomyopathy by first pretraining a feature extractor to predict blood-biomarker levels from MIMIC-IV-ECG data, then fine-tuning on Brazilian CODE-15%, SaMi-Trop, and PTB-XL recordings; the final model is a 5-model ensemble. Submitted to the George B. Moody PhysioNet Challenge 2025 (Detection of Chagas Disease from the ECG), where it placed 5th on the official leaderboard. Developed by a team from Akershus University Hospital and the University of Oslo.